Skip to main content
SpringerLink
Log in
Book cover

Orthopaedic Oncology pp 151–170Cite as

Evaluation and Treatment of Extremity Metastatic Disease

Part of the Cancer Treatment and Research book series (CTAR,volume 162)

Abstract

Metastases can occur as part of the natural progression of a variety of malignancies and their mode of spread, manner of presentation, and prognosis are as variable as their primary sources. The ultimate goal of musculoskeletal treatment of skeletal metastases is to get the patient in question back to his or her previous level of function as soon as possible. Skeletal metastases are seldom life threatening and their treatment will rarely render someone cured of their primary disease. Nevertheless, involvement of a musculoskeletal specialist as a part of the multidisciplinary approach can and very often does provide significant improvement in patients’ qualities of life. The purpose of this chapter is to discuss the evaluation of a patient with suspected metastatic disease involving the musculoskeletal system and their pre-, intra-, and post surgical management as part of a multidisciplinary team.

Keywords

  • Musculoskeletal
  • Metastasis
  • Carcinoma
  • Bisphosphonate

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Weber K (2010) Evaluation of the adult patient with a destructive bone lesion. J Am Acad Orthopedic Surgery 18:169–179

    Google Scholar 

  2. Coleman R et al (2010) Metastasis and bone loss: advancing treatment and prevention. Cancer Treat Rev 36(8):615–620 (Published online 2010 May 15)

    Google Scholar 

  3. Narazaki DK, Alverga Neto CC, Baptista AM, Caiero MT, Camargo OP (2006) Prognostic factors in pathologic fractures secondary to metastatic tumors Clinics 61(4):313–320

    Google Scholar 

  4. Coleman R (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s

    CrossRef  PubMed  Google Scholar 

  5. Jasmin C, Coleman, RE, Coia LR, Capanna R, Saillant G (2005) Textbook of bone metastases. Wiley, London

    Google Scholar 

  6. Sivasundaram R, Shah S, Ahmadi S, Wunder JS, Schemitsch EH, Ferguson PC, Zdero R (2013) The biomechanical effect of proximal tumor defect location on femur pathological fractures. J Orthopedic Trauma 27(8):e174–e180

    CrossRef  Google Scholar 

  7. Higinbotham NL, Marcove RC (1965) The management of pathological fractures. J Trauma 5:792–798

    CrossRef  CAS  PubMed  Google Scholar 

  8. Healey JH, Brown HK (2000) Complications of bone metastases: surgical management. Cancer 88(S12):2940–2951

    CrossRef  CAS  PubMed  Google Scholar 

  9. Ahn SG, Lee HM, Cho S-H, Lee SA, Hwang SH, Jeong J, Lee H-D (2013) Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J 54(5):1168–1177

    Google Scholar 

  10. Bloomfield DJ (1998) Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. J Clin Oncol 16:1218–1225

    CAS  PubMed  Google Scholar 

  11. Katzmann JA (2009) Screening panels for monoclonal Gammopathiesltime to change. Clin Biochem Rev 30(3):105–111

    PubMed Central  PubMed  Google Scholar 

  12. Jung K et al (2004) Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int J Cancer 111(5):783–791

    CrossRef  CAS  PubMed  Google Scholar 

  13. Aydiner A (1994) Serum tumor markers for detection of bone metastasis in breast cancer patients. Acta Oncol 33(2):181–186

    CrossRef  CAS  PubMed  Google Scholar 

  14. Mundy G (2002) Metastasis to bone: causes, consequences, and therapeutic opportunities. Cancer 2:584–593

    CAS  PubMed  Google Scholar 

  15. McNeil BJ (1984) Value of bone scanning in neoplastic disease. Semin Nucl Med 14:277–286

    CrossRef  CAS  PubMed  Google Scholar 

  16. Damle NA, Bal C, Bandopadhyaya GP, Kumar L, Kumar P, Malhotra A, Lata S (2013) The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan. Jpn J Radiol 31(4):262–269

    CrossRef  PubMed  Google Scholar 

  17. Rougraff BR, Kneisl JS, Simon MA (1993) Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am 75:1276–1281

    CAS  PubMed  Google Scholar 

  18. Clayer M, Duncan W (2006) Importance of biopsy of new bone lesions in patients with previous carcinoma. Clin Orthop Rel Res 451:208–211

    CrossRef  Google Scholar 

  19. Cronin CG, Cashell T, Mhuircheartaigh JN, Swords R, Murray M, O’Sullivan GJ, O’Keeffe D (2009) AJR Am J Roentgenol 193(5):W407–W410

    CrossRef  PubMed  Google Scholar 

  20. Ward WG, Kilpatrick S (2000) Fine-needle aspiration biopsy of primary bone tumors. Clin Orthop Relat Res 373:80–87

    CrossRef  PubMed  Google Scholar 

  21. Yang YJ, Damron TA (2004) Comparison of needle core biopsy and fine-needle aspiration for diagnostic accuracy in musculoskeletal lesions. Arch Pathol Lab Med 128(7):759–764

    PubMed  Google Scholar 

  22. Mankin HJ, Mankin CJ, Simon MA (1996) The hazards of the biopsy, revisited. For the members of the musculoskeletal tumor society. J Bone Joint Surg 78(5):656–663

    CAS  PubMed  Google Scholar 

  23. Ward WG, Savage P, Boles C, Kilpatrick SE (2001) Fine-needle aspiration biopsy of sarcomas and related tumors. Cancer Control 8(3):232–238

    CAS  PubMed  Google Scholar 

  24. Wong R, Wiffen PJ (2002) Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002(2):CD002068

    Google Scholar 

  25. Finley RS (2002) Bisphophonates in the treatment of bone meatastases. Sem Onc 29(1)(4):132–138

    Google Scholar 

  26. Walkington L, Coleman RE (2011) Advances in management of bone disease in breast cancer. Bone 48(1):80–87

    CrossRef  CAS  PubMed  Google Scholar 

  27. Groot MT, Boeken Kruger CGG, Peiger RCM, Uyl-de Groot CA (2003) Costs of prostate cancer, metastatic to the bone in the Netherlands. Eur Urol 43(3):226–232

    Google Scholar 

  28. Jeremic B (2001) Single fraction external beam radiation therapy in the treatment of localized metastatic bone pain. a review. J Pain Symptom Manage 22(6):1048–1058

    CrossRef  CAS  PubMed  Google Scholar 

  29. Callstrom MR, Dupuy DE, Solomon SB, Beres RA, Littrup PJ, Davis KW, Paz-Fumagalli R, Hoffman C, Atwell TD, Charboneau JW, Schmit GD, Goetz MP, Rubin J, Brown KJ, Novotny PJ, Sloan JA (2013) Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 119(5):1033–1041

    CrossRef  PubMed  Google Scholar 

  30. Toyota N, Naito A et al (2005) Radiofrequency ablation therapy combined with cementoplasty for painful bone metastases: initial experience. Cardiovasc Intervent Radiol 28(5):578–583

    Google Scholar 

  31. Fidler M (1973) Prophylactic internal fixation of secondary neoplastic deposits in long bones. BMJ 1(5849):341

    CrossRef  CAS  PubMed Central  PubMed  Google Scholar 

  32. Mirels H (1989) Metastatic disease in long bones a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 249:256–264

    PubMed  Google Scholar 

  33. Robial N, Charles YP, Bogorin I, Godet J, Beaujeux R, Boujan F, Steib JP (2012) Is preoperative embolization a prerequisite for spinal metastases surgical management? Orthop Traumatol Surg Res 98(5):536–542

    CrossRef  CAS  PubMed  Google Scholar 

  34. Fang T, Dong J, Zhou X, McGuire RA Jr, Li X (2012) Comparison of mini-open anterior corpectomy and posterior total en bloc spondylectomy for solitary metastases of the thoracolumbar spine. J Neurosurg Spine 17(4):271–279

    CrossRef  PubMed  Google Scholar 

  35. Nilsson J, Gustafson P, Fornander P, Ornstein E (2000) The Harrington reconstruction for advanced periacetabular metastatic destruction: good outcome in 32 patients. Acta Orthopaedica 71(6):591–596

    CrossRef  CAS  Google Scholar 

  36. Vena VE, Hsu J, Rosier RN, O’Keefe RJ (1999) Pelvic reconstruction for severe periacetabular metastatic disease. Clin Orthop Relat Res 362:171–180

    PubMed  Google Scholar 

  37. Walker RH (1993) Pelvic reconstruction/total hip arthroplasty for metastatic acetabular insufficiency. Clin Orthop Relat Res 294:170–175

    PubMed  Google Scholar 

  38. Allan DG, Bell RS, Davis A, Langer F (1995) Complex acetabular reconstruction for metastatic tumor. J Arthroplasty 10(3):301–306

    CrossRef  CAS  PubMed  Google Scholar 

  39. Wedin R, Bauer HCF (2005) Surgical treatment of skeletal metastatic lesions of the proximal femur Endoproththesis or reconstruction nail? J Bone Joint Surg Br 87(12):1653–1657

    Google Scholar 

  40. Ashford RU et al (2012) The modern surgical and non-surgical management of appendicular skeletal metastases. Orthop Trauma 26(3):184–199

    Google Scholar 

  41. Frassica FJ, Frassica DA (2003) Evaluation and treatment of metastases to the humerus. Clin Orthop Relat Res 415:S212–S218

    CrossRef  PubMed  Google Scholar 

  42. Hill C et al (1981) Prophylactic cefazolin versus placebo in total hip replacement report of a multicentre double-blind randomised trial. Lancet 1(8224):795–796

    CrossRef  CAS  PubMed  Google Scholar 

  43. Donati D, Biscaglia R (1998) The use of antibiotic-impregnated cement in infected reconstructions after resection for bone tumours. J Bone Joint Surg Br 80(6):1045–1050

    CrossRef  CAS  PubMed  Google Scholar 

  44. Bickels J, Kollender Y, Wittig JC, Cohen N, Meller I, Malawer MM (2005) Vacuum-assisted wound closure after resection of musculoskeletal tumors. Clin Orthop Relat Res 441:346–350

    CrossRef  PubMed  Google Scholar 

  45. Falanga A, Rickles FR (1999) Pathophysiology of the thrombophilic state in the cancer patient. In: Seminars in thrombosis and hemostasis, vol 25, issue 02. Thieme Medical Publishers Inc, New York, pp 173–182

    Google Scholar 

  46. Townsend PW, Rosenthal HG, Smalley SR, Cozad SC, Hassanein RE (1994) Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 12(11):2345–2350

    CAS  PubMed  Google Scholar 

  47. Fuchs B, Trousdale RT, Rock MG (2005) Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop Relat Res 431:187–192

    CrossRef  PubMed  Google Scholar 

  48. Evenski A, Ramasunder S, Fox W, Mounasamy V, Temple HT (2012) Treatment and survival of osseous renal cell carcinoma metastases. J Surg Oncol 106(7):850–855

    CrossRef  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Greenville Health System, Greenville, SC, 29605, USA

    Aaron T. Creek, Drew A. Ratner & Scott E. Porter

Authors
  1. Aaron T. Creek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Drew A. Ratner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott E. Porter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott E. Porter .

Editor information

Editors and Affiliations

  1. Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Terrance D. Peabody

  2. Department of Orthopaedic Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Samer Attar

Rights and permissions

Reprints and Permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Creek, A.T., Ratner, D.A., Porter, S.E. (2014). Evaluation and Treatment of Extremity Metastatic Disease. In: Peabody, T., Attar, S. (eds) Orthopaedic Oncology. Cancer Treatment and Research, vol 162. Springer, Cham. https://doi.org/10.1007/978-3-319-07323-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-07323-1_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-07322-4

  • Online ISBN: 978-3-319-07323-1

  • eBook Packages: MedicineMedicine (R0)

search

Navigation